Abstract
In this work, the anti-Escherichia coli activity of the bioactive substances produced by Bacillus amyloliquefaciens R3 was examined. A new and cheap medium for production of the anti-E. coli substances which contained 20.0 g L−1 soybean powder, 20.0 g L−1 wheat flour, pH 6.0 was developed. A crude surfactant concentration of 0.48 mg mL−1 was obtained after 27 h of 10-L fermentation, and the diameter of the clear zone on the plate seeded with the pathogenic E. coli 2# was 23.3 mm. A preliminary characterization suggested that the anti-E. coli substances produced by B. amyloliquefaciens R3 were the biosurfactins (F1, F2, F3, F4, and F5) with amino acids (GLLVDLL) and hydroxy fatty acids (of 12–15 carbons in length). It was found that all the strains of the pathogenic E. coli showed resistance to several different antibiotics, suggesting that they were the multi-drug resistance and all the strains of the pathogenic E. coli were sensitive to the biosurfactins, indicating that the biosurfactins produced by B. amyloliquefaciens R3 had a broad spectrum of antibacterial activity against the pathogenic E. coli with multi-drug resistant profiles. After the treatment with the purified biosurfactin (F1), the cell membrane of both the whole cells and protoplasts of the E. coli 2# was damaged and the whole cells of the bacterium were broken.
Similar content being viewed by others
References
Dobrindt U, Hacker J (2008) Targeting virulence traits: potential strategies to combat extraintestinal pathogenic E. coli infections. Cur Opin Microbiol 11:409–413
Murray PR, Rosenthal KS, Pfaller MA (2009) Medical microbiology, 6th edn. Mosby Elsevier, Philadelphia, pp 301–315
Mora A, Viso S, Lopez C, Alonso MP, Garcıa-Garrote F, Dabhi G, Mamani R, Herrera A, Marzoa J, Blanco M, Blanco JE, Moulin-Schouleur M, Schouler C, Blanco J (2013) Poultry as reservoir for extraintestinal pathogenic Escherichia coli O45:K1:H7-B2-ST95 in humans. Vet Microbiol 167:506–512
Dheilly A, Devendec LL, Mourand G, Jouy E, Kempf I (2013) Antimicrobial resistance selection in avian pathogenic E. coli during treatment. Vet Microbiol 166:655–658
Yen CC, Shen CJ, Hsu WH, Chang YH, Lin HT (2011) Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection. Biometals 24:585–594
Wong JH, Hao J, Cao Z, Qiao M, Xu H, Bai Y (2008) An antifungal protein from Bacillus amyloliquefaciens. J Appl Microbiol 105:1888–1898
Sambrook J, Fritsch EF, Maniatis T (1989) Preparation and analysis of eukaryotic genomic DNA. Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Beijing, pp 367–370
Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mole Biol Evol 24:1596–1599
Song B, Rong YJ, Zhao MX, Chi ZM (2013) Antifungal activity of the lipopeptides produced by Bacillus amyloliquefaciens anti-CA against Candida albicans isolated from clinic. Appl Microbiol Biotechnol 97:7141–7150
Xu HM, Rong YJ, Zhao MX, Song B, Chi ZM (2014) Antibacterial activity of the lipopeptides produced by Bacillus amyloliquefaciens M1 against multidrug-resistant Vibrio spp. isolated from diseased marine animals. Appl Microbiol Biotechnol 98:127–136
Da MH, Ziesman S, Ratcliffe T, Gill RT, Copley SD (2005) Visualization of protoplast fusion and quantitation of recombination in fused protoplasts of auxotrophic strains of Escherichia coli. Metab Eng 7:45–52
Sun L, Lu Z, Bie X, Lu F, Yang S (2006) Isolation and characterization of a co-producer of fengycins and surfactins, endophytic Bacillus amyloliquefaciens ES-2, from Scutellaria baicalensis Georgi. World J Microbiol Biotechnol 22:1259–1266
Fernandes PAV, Arruda IRD, Santo AFABD (2007) Antimicrobial activity of surfactants produced by Bacillus subtilis R14 against multidrug-resistant bacteria. Braz J Microbiol 38:704–709
Ramos S, Silva N, Canic M, Capelo-Martinez JL, Brito F, Igrejas G (2013) High prevalence of antimicrobial-resistant Escherichia coli from animals at slaughter: a food safety risk. J Sci Food Agri 93:517–526
Alvarez F, Castro M, Príncipe A, Borioli G, Fischer S, Mori G (2011) The plant-associated Bacillus amyloliquefaciens strains MEP218 and ARP23 capable of producing the cyclic lipopeptides iturin or surfactin and fengycin are effective in biocontrol of sclerotinia stem rot disease. J Appl Microbiol 112:159–174
Duncan SH, Flint HJ, Stewart CS (1998) Inhibitory activity of gut bacteria against Escherichia coli O157 mediated by dietary plant metabolites. FEMS Microbiol Lett 164:283–288
Appendini P, Hotchkiss JH (1999) Antimicrobial activity of a 14-residue peptide against Escherichia coli O157:H7. J Appl Microbiol 87:750–756
Ye X, Li P, Yu Q, Yang Q (2013) Bacillus subtilis inhibition of enterotoxic Escherichia coli-induced activation of MAPK signaling pathways in Caco-2 cells. Ann Microbiol 63:577–581
Collins JW, Ragione RM, Woodward MJ, Searle LEJ (2009) Application of prebiotics and probiotics in livestock. Springer Sciencet Business Media, LLC, New York, pp 1123–1192
Viscardi M, Perugini AG, Auriemma C, Capuano F, Morabito S (2008) Isolation and characterisation of two novel coliphages with high potential to control antibiotic-resistant pathogenic Escherichia coli (EHEC and EPEC). Intern J Antimicrob Agents 3:152–157
Oelschlaeger T, Dobrindt U, Hacker J (2002) Pathogenicity islands of uropathogenic E. coli and the evolution of virulence. Intern J Antimicrob Agents 19:517–521
Yang J, Huang K, Qin S, Wu X, Zhao Z, Chen F (2009) Antibacterial action of selenium-enriched probiotics against pathogenic Escherichia coli. Dig Dis Sci 54:246–254
Acknowledgments
This work was supported by Grant 30771645 from National Natural Science Foundation of China.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chi, Z., Rong, YJ., Li, Y. et al. Biosurfactins production by Bacillus amyloliquefaciens R3 and their antibacterial activity against multi-drug resistant pathogenic E. coli . Bioprocess Biosyst Eng 38, 853–861 (2015). https://doi.org/10.1007/s00449-014-1328-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00449-014-1328-9